Niki Pandria, Vasileia Petronikolou, Aristotelis Lazaridis, Christos Karapiperis, Eleftherios Kouloumpris, Dimitrios Spachos, Anestis Fachantidis, Dimitrios Vasileiou, Ioannis Vlahavas and Panagiotis Bamidis. “Information System for Symptom Diagnosis and Improvement of Attention Deficit Hyperactivity Disorder: Protocol for a Nonrandomized Controlled Pilot Study”. JMIR Research Protocols, JMIR Publications, 2022, https://doi.org/10.2196/40189.

Author(s): Niki Pandria, Vasileia Petronikolou, Aristotelis Lazaridis, Christos Karapiperis, Eleftherios Kouloumpris, Dimitrios Spachos, Anestis Fachantidis, Dimitrios Vasileiou, Ioannis Vlahavas, Panagiotis Bamidis

Availability:

Keywords: adhd, serious games, machine learning, diagnosis, adhd360

Tags:

Abstract: Background: Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders during childhood, however the diagnosis procedure remains challenging as it is non-standardized, multi-parametric and highly dependent on subjective evaluation of the perceived behavior. Objective: To address the challenges of existing procedures for ADHD diagnosis, the ADHD360 project aims to develop a platform for (a) early detection of ADHD by assessing the user’s likelihood of having ADHD characteristics and (b) providing complementary training for ADHD management. Methods: A two-phase pilot study was designed to evaluate the ADHD360 platform, including ADHD and non-ADHD participants aged 7-16 years. Machine Learning methods were used to detect discriminative gameplay patterns among the two groups (ADHD, non-ADHD) and estimate a player’s likelihood of having ADHD characteristics. Results: A preliminary analysis of collected data showed that the trained models achieve high performance in correctly predicting a user’s label (ADHD or non-ADHD) from his gameplay session in the ADHD360 platform. Conclusions: ADHD360 is characterized by notable capacity to discriminate player gameplay behavior as either ADHD or non-ADHD. Therefore, the ADHD360 platform could be a valuable complementary tool for early ADHD detection. Clinical Trial: ClinicalTrials.gov NCT04362982